Triptolide induces apoptosis through the calcium/calmodulin ‑dependent protein kinase kinaseβ/AMP‑activated protein kinase signaling pathway in non‑small cell lung cancer cells.

In conclusion, the results of the present study suggested that triptolide may induce apoptosis through the CaMKKβ‑AMPK signaling pathway and may be a promising drug for the treatment of NSCLC. PMID: 33000264 [PubMed - in process]

https://www.ncbi.nlm.nih.gov/pubmed/33000264?dopt=Abstract

Source: Oncology Reports - October 3, 2020 Category: Cancer & Oncology Tags: Oncol Rep Source Type: research